C WorldWide Group Holding A/S
Position in KPTI — Karyopharm Therapeutics Inc.
CIK 1625244
COPENHAGEN, G7
Position in KPTI
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$557,000
-$179,000 QoQ
Shares Held
100,000
0.0% QoQ
Ownership
0.441%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in KPTI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026C WorldWide Group Holding A/S holds $185,024,468 across 13 Biotechnology names. KPTI ranks #13 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
661,776 | $31,745,394 | |
| 2 | IONS |
Ionis Pharmaceuticals Inc
|
366,000 | $27,482,940 | |
| 3 | INSM |
INSMED Inc
|
161,110 | $26,344,707 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
46,057 | $20,566,292 | |
| 5 | KRYS |
Krystal Biotech, Inc.
|
67,809 | $17,516,420 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
267,851 | $15,130,902 | |
| 7 | PCVX |
Vaxcyte, Inc.
|
195,000 | $11,331,450 | |
| 8 | SRPT |
Sarepta Therapeutics, Inc.
|
490,329 | $10,669,559 |
All Filings in KPTI
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $557,000 | 100,000 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $736,000 | 100,000 | Shares | Defined | 2026-02-04 | |
| 2025-09-30 | $654,000 | 100,000 | Shares | Defined | 2025-11-05 | |
| 2025-06-30 | $431,000 | 100,000 | Shares | Defined | 2025-08-06 | |
| 2025-03-31 | $374,000 | 100,000 | Shares | Defined | 2025-05-05 | |
| No filing history on record for this holder in this stock. | ||||||